IRIS
VESPASIANI GENTILUCCI, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.660
NA - Nord America 1.089
EU - Europa 592
OC - Oceania 25
AF - Africa 17
SA - Sud America 12
Totale 9.395
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.598
US - Stati Uniti d'America 1.051
HK - Hong Kong 559
CN - Cina 409
GB - Regno Unito 168
IT - Italia 159
DE - Germania 101
IN - India 37
FI - Finlandia 34
NL - Olanda 33
CA - Canada 29
CZ - Repubblica Ceca 28
AU - Australia 24
TR - Turchia 20
UA - Ucraina 16
FR - Francia 14
PL - Polonia 12
JP - Giappone 11
ZA - Sudafrica 9
BR - Brasile 7
MX - Messico 6
ES - Italia 5
ET - Etiopia 4
ID - Indonesia 4
SA - Arabia Saudita 4
BD - Bangladesh 3
CH - Svizzera 3
CL - Cile 3
IR - Iran 3
MA - Marocco 3
SE - Svezia 3
AT - Austria 2
BE - Belgio 2
KR - Corea 2
KZ - Kazakistan 2
PA - Panama 2
PH - Filippine 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 9.395
Salva come PNG Salva come JPEG
Città #
Hong Kong 550
Singapore 372
Ashburn 267
Boardman 216
Hefei 197
London 149
Shanghai 134
Rome 70
Munich 52
Council Bluffs 37
Los Angeles 37
San Francisco 37
Seattle 30
Brno 28
Pune 26
West Jordan 22
Santa Clara 19
Turku 19
Amsterdam 18
Toronto 17
Washington 17
Helsinki 15
New York 15
Canberra 12
Sona 11
Warsaw 11
Tokyo 10
Guangzhou 8
Melbourne 7
Redmond 6
Brooklyn 5
Chicago 5
Milan 5
Montreal 5
Paris 5
Sydney 5
São Paulo 5
Central 4
Frankfurt am Main 4
Naples 4
The Dalles 4
Zhengzhou 4
Addis Ababa 3
Bari 3
Bologna 3
Boston 3
Brownsville 3
Camden 3
Charlotte 3
Haikou 3
Johannesburg 3
Kyiv 3
Mexico City 3
Rabat 3
Riyadh 3
Stockholm 3
Valsamoggia 3
Anderlecht 2
Andover 2
Ankara 2
Atlanta 2
Berlin 2
Boydton 2
Buffalo 2
Cervignano del Friuli 2
Cinisello Balsamo 2
Dallas 2
Delhi 2
Falls Church 2
Ferrara di Monte Baldo 2
Foligno 2
Handan 2
Hangzhou 2
Hanover 2
Houston 2
Kharkiv 2
Las Vegas 2
Liverpool 2
Manchester 2
Messina 2
Newark 2
Perugia 2
Rovereto 2
Salt Lake City 2
Secaucus 2
Shenzhen 2
Shijiazhuang 2
Suzhou 2
Tianjin 2
Torino 2
Vienna 2
Xingtai 2
Zurich 2
Almere Stad 1
Augusta 1
Basingstoke 1
Beijing 1
Bengaluru 1
Bratislava 1
Budapest 1
Totale 2.588
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 209
Advances in management of periprosthetic joint infections: an historical prospective study 196
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 193
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 193
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 190
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 188
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 187
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 185
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 183
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 183
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 183
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 182
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 180
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 180
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 179
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 179
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 178
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 178
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 173
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 171
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 170
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 170
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 170
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 167
Assessment of liver function by the exhaled breath-print during chronic liver disease 166
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 121
GH-resistance in different stages of chronic liver disease 96
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 94
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 93
Diabetes in chronic liver disease: from old concepts to new evidence 92
[A 73-year-old woman with vomiting and metabolic alkalosis] 91
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 89
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 89
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 86
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 82
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 82
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 81
A challenging alfa-fetoprotein in a cirrhotic patient 80
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 79
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 79
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 76
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 75
[A 61-year-old woman with abdominal pain and urination disorders] 75
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 75
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 75
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 75
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 74
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 72
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 72
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 68
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 67
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 63
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 62
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 60
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 58
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 56
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 55
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 54
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 50
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 42
TNF-alpha and growth hormone resistance in patients with chronic liver disease 30
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 29
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 27
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 27
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 26
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 26
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 25
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 25
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 25
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 25
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 25
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. 25
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 25
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 25
The pharmacological treatment of chronic comorbidities in COPD: mind the gap! 24
Reply 23
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b 23
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 23
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 22
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 22
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 22
Reelin expression in human liver of patients with chronic hepatitis C infection 22
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 22
Raised C-reactive protein levels in patients with recent onset type 1 diabetes 22
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 22
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 21
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 21
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 21
SINDROME DI SJÖGREN (SS) ASSOCIATA A MALATTIA INFIAMMATORIA PELVICA (PID): DESCRIZIONE DI UN CASO CLINICO 21
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver inury 21
Pain and Frailty in Hospitalized Older Adults 21
The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period 21
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 20
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension 20
Hepatic complications of bariatric surgery : the reverse side of the coin 20
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 20
Tubercolomi cerebrali multipli resistenti alla terapia convenzionale in un soggetto immunosoppresso [Multiple cerebral tuberculomas resistant to conventional therapy in an immunocompromised subject] 20
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 20
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 20
Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation 20
Totale 8.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 2 8 0 3 3 2 6 46 4 4 258
2022/2023112 12 1 6 4 10 2 30 4 3 5 33 2
2023/2024636 26 50 18 62 61 269 2 37 8 40 20 43
2024/20258.381 131 57 236 45 110 186 143 34 482 562 3.017 3.378
2025/20265 5 0 0 0 0 0 0 0 0 0 0 0
Totale 9.470